Lung cancer is the leading cause of cancer-related mortality in the United States and is comprised of two main histologic subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Fortunately, advanced drug therapies and genetic testing are making a big difference for many patients and their families.
Hear from highly-regarded lung cancer experts, nurse practitioners and patients from across the globe by viewing our interviews.
Upcoming EventsSee all events
Wednesday, August 26, 2020
What's the latest treatment news for lung cancer patients with the KRAS (Kirsten rat sarcoma viral oncogene homologue) mutation? Join us on Wednesday, August 26th at 3:30 pm PT/5:30 pm CT for our Lung Cancer Answers Now program.